scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...989810F |
P356 | DOI | 10.1371/JOURNAL.PONE.0089810 |
P932 | PMC publication ID | 3933653 |
P698 | PubMed publication ID | 24587052 |
P5875 | ResearchGate publication ID | 260448313 |
P50 | author | Jennifer I Drake | Q84481804 |
P2093 | author name string | Harm J Bogaard | |
Carlyne D Cool | |||
Norbert F Voelkel | |||
Laszlo Farkas | |||
Daniela Farkas | |||
Donatas Kraskauskas | |||
Vita Kraskauskiene | |||
Aysar A Alhussaini | |||
P2860 | cites work | Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor | Q24318673 |
Molecular pathogenesis of pulmonary arterial hypertension | Q24634317 | ||
Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. | Q52118613 | ||
Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. | Q53512178 | ||
C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. | Q54379158 | ||
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. | Q54646705 | ||
SDF-1α/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells | Q56921714 | ||
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension | Q59261131 | ||
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis | Q61892487 | ||
Role of c-kit/Kit ligand signaling in regulating vasculogenesis | Q79092300 | ||
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells | Q80474847 | ||
Vascular wall resident progenitor cells: a source for postnatal vasculogenesis | Q82766257 | ||
Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke | Q83332757 | ||
Stem cells and cell therapies in lung biology and lung diseases | Q84303950 | ||
Formation of plexiform lesions in experimental severe pulmonary arterial hypertension | Q84404717 | ||
Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats | Q28569530 | ||
CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity | Q28587353 | ||
Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment | Q29346986 | ||
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
Updated clinical classification of pulmonary hypertension. | Q30378433 | ||
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis | Q33942836 | ||
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. | Q34228118 | ||
Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell | Q34307717 | ||
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report | Q34535086 | ||
Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide | Q34829342 | ||
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. | Q35010981 | ||
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage | Q35087969 | ||
Evidence for human lung stem cells | Q35399248 | ||
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension | Q35833414 | ||
Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension | Q36163044 | ||
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. | Q36769644 | ||
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation | Q36959863 | ||
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents | Q37111334 | ||
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats | Q37170742 | ||
The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? | Q37374031 | ||
Reversible or irreversible remodeling in pulmonary arterial hypertension | Q37653353 | ||
Strategies for homeostatic stem cell self-renewal in adult tissues | Q37887870 | ||
A review on CXCR4/CXCL12 axis in oncology: no place to hide. | Q38017493 | ||
Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells | Q40421753 | ||
New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis | Q41853468 | ||
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension | Q42641623 | ||
The cancer paradigm of severe pulmonary arterial hypertension | Q42682888 | ||
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. | Q43043847 | ||
Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice | Q44018101 | ||
Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. | Q44977498 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary hypertension | Q1128595 |
P304 | page(s) | e89810 | |
P577 | publication date | 2014-02-24 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats | |
P478 | volume | 9 |
Q60935302 | Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension |
Q92932841 | Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia |
Q90822809 | Effects of masitinib compared with tadalafil for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats |
Q90714004 | Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats |
Q52583184 | Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension. |
Q64082260 | Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension |
Q97548235 | HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension |
Q54964312 | High expression of CXCR4 and stem cell markers in a monocrotaline and chronic hypoxia-induced rat model of pulmonary arterial hypertension. |
Q48042730 | Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. |
Q64244878 | Involvement of CXCR4 in Normal and Abnormal Development |
Q34305561 | Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats. |
Q92924608 | Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways |
Q38709505 | Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension |
Q37747432 | Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells |
Q64090954 | Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia |
Q36797479 | Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway |
Q45046014 | The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension |
Search more.